4615-71-8 Usage
Description
5-(2-FURYL)-5-METHYLIMIDAZOLIDINE-2,4-DIONE, commonly known as acemetacin, is a non-steroidal anti-inflammatory drug (NSAID) characterized by its ability to alleviate pain and inflammation associated with various conditions, including arthritis. It operates by inhibiting the synthesis of prostaglandins, which are responsible for pain and inflammation within the body. As an oral medication, acemetacin is available in tablet or capsule form and is effective for managing moderate to severe pain. However, its use may be accompanied by side effects such as gastrointestinal irritation, ulcers, and bleeding, particularly with long-term or high-dose administration. It is crucial to adhere to the prescribed dosage and seek medical advice before initiating treatment with acemetacin.
Uses
Used in Pharmaceutical Industry:
5-(2-FURYL)-5-METHYLIMIDAZOLIDINE-2,4-DIONE is used as an anti-inflammatory and analgesic agent for the treatment of conditions such as arthritis, where it helps to reduce pain and inflammation by inhibiting prostaglandin production. Its effectiveness in managing moderate to severe pain makes it a valuable component in pain management therapies.
Used in Pain Management:
5-(2-FURYL)-5-METHYLIMIDAZOLIDINE-2,4-DIONE serves as a therapeutic intervention for individuals experiencing moderate to severe pain, providing relief by targeting the biochemical pathways that lead to pain sensation and inflammation.
Check Digit Verification of cas no
The CAS Registry Mumber 4615-71-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,6,1 and 5 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 4615-71:
(6*4)+(5*6)+(4*1)+(3*5)+(2*7)+(1*1)=88
88 % 10 = 8
So 4615-71-8 is a valid CAS Registry Number.
InChI:InChI=1/C8H8N2O3/c1-8(5-3-2-4-13-5)6(11)9-7(12)10-8/h2-4H,1H3,(H2,9,10,11,12)/t8-/m1/s1
4615-71-8Relevant articles and documents
AMIDOALKYLPIPERAZINYL DERIVATIVES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES
-
Page/Page column 29; 30, (2013/03/26)
The invention relates to novel amidoalkylpiperazinyl derivatives of tricyclic heterocyclic systems of general formula (I), wherein Z represents -NH- and X represents -S-, or Z represents -S- and X represents >C=C1 represents H or -CH3, R6 and R7 both represent H, n is an integer from 0 to 4 inclusive, G represents a cyclic amide or imide moiety, and optical isomers, geometric isomers, and pharmaceutically acceptable salts thereof. The compounds may be useful for the treatment and/or prevention of the central nervous system disorders.
